Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesetaxel plus capecitabine in second-line gastric cancer
NCT01573468Phase 2Unknown
- Sponsor
- Genta Incorporated
- Start
- Apr 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of tesetaxel in gastric adenocarcinoma, sponsored by Genta Incorporated. Status: unknown.
02
Drugs
tesetaxel
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT01573468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01573468.